• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON DICKINSON UNSPECIFIED BD ALARIS¿ PRIMARY SET; INTRAVASCULAR ADMINISTRATION SET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON DICKINSON UNSPECIFIED BD ALARIS¿ PRIMARY SET; INTRAVASCULAR ADMINISTRATION SET Back to Search Results
Catalog Number UNKNOWN
Device Problem Obstruction of Flow (2423)
Patient Problem Low Blood Pressure/ Hypotension (1914)
Event Date 02/09/2023
Event Type  Injury  
Manufacturer Narrative
Unknown manufacturer: there are multiple bd locations where this unspecified bd device may have been manufactured.A catalog and lot number could not be confirmed for this incident and without this information we are unable to determine where the device was manufactured.Therefore, bd corporate headquarters in franklin lakes, nj has been listed in report.And the franklin lakes fda registration number has been used for the manufacture report number.Medical device expiration date: unknown.A device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.Device manufacture date: unknown.
 
Event Description
It was reported that the unspecified bd alaris¿ primary set was blocked during the infusion.As a result, the patient required titration of norepinephrine until a new norepinephrine line could be mixed and hung.The following information was provided by the initial reporter: "a psls event was reported regarding an alaris pump not alarming for a patient receiving a norepinephrine infusion involving a pump (15921996) and channel (14057561) rn trouble shooting issue and noted infusion was not dripping.Alaris pump did not alarm and gave no indication that fluid was not being delivered.Iv tubing removed from channel and on inspection it was noted that tubing appeared to be fused together inside channel.What additional medical intervention was provided to the patient because of the event? (e.G., titration of norepinephrine, administration of extra fluids and/or additional medication): titration of norepinephrine until new line of norepinephrine could be mixed and hung.What was the patient¿s outcome? no harm".
 
Event Description
It was reported that the unspecified bd alaris¿ primary set was blocked during the infusion.As a result, the patient required titration of norepinephrine until a new norepinephrine line could be mixed and hung.The following information was provided by the initial reporter: "a psls event was reported regarding an alaris pump not alarming for a patient receiving a norepinephrine infusion involving a pump (b)(6) and channel (b)(6) rn trouble shooting issue and noted infusion was not dripping.Alaris pump did not alarm and gave no indication that fluid was not being delivered.Iv tubing removed from channel and on inspection it was noted that tubing appeared to be fused together inside channel.What additional medical intervention was provided to the patient because of the event? (e.G., titration of norepinephrine, administration of extra fluids and/or additional medication): titration of norepinephrine until new line of norepinephrine could be mixed and hung.What was the patient¿s outcome? no harm".
 
Manufacturer Narrative
The following fields were updated due to additional information: d10: device available for eval yes.D10: returned to manufacturer on: 17-apr-2023.H6: investigation summary: one sample model 10010483 was returned for investigation.The set was examined for defects and abnormalities.The tubing was fused at the silicone segment.The customer¿s returned set model #10010483 was observed to be fused where the pumping segment lines up with the upper and lower occluder fingers.After massaging the fused segments open, functional testing of the administration set showed no anomalies.Fused tubing is the result of leaving tubing in the pumping chamber for an extended period of time and can result in a vacuum leading to no infusion therapy provided, and no occlusion detection alarm indication.The pump chamber blocked tip sheet (dir (b)(6)) instructs the user as follows: cause: if the tubing inside the pump is held under fixed compression for a prolonged period of time, it will fuse closed on occasion.A device history record review could not be performed because a lot number was not provided by the customer.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
UNSPECIFIED BD ALARIS¿ PRIMARY SET
Type of Device
INTRAVASCULAR ADMINISTRATION SET
Manufacturer (Section D)
BECTON DICKINSON
1 becton drive
franklin lakes NJ 07417
Manufacturer (Section G)
BECTON DICKINSON
1 becton drive
franklin lakes NJ 07417
Manufacturer Contact
phillip emmert
9450 south state street
sandy, UT 84070
8448235433
MDR Report Key16503875
MDR Text Key310911228
Report Number2243072-2023-00327
Device Sequence Number1
Product Code FPA
Combination Product (y/n)N
Reporter Country CodeCA
PMA/PMN Number
UNKNOWN
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 06/05/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/08/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberUNKNOWN
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Date Manufacturer Received06/05/2023
Was Device Evaluated by Manufacturer? Yes
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-